PCI Pharma Services announces $20M expansion for biotech packaging

PCI Pharma Services invested over $20 million to expand biotech clinical and commercial packaging and release testing capability at its Center of Excellence in Philadelphia, and expand cold chain capacity at global locations.

“It’s estimated that close to 40 per cent of all medicines in pipeline development are biologic, and amazing new therapies are being developed and commercialized every day.”drug-dev.com

• 1 source
• drug-dev.comPCI Pharma Services Announces $20-Million Expansion of Biotech Technologies, Including Advanced Injectable Delivery FormsDan MarinoJan 7, 2019

Summarized from public sources; check the original articles before acting on it.